Medical Billing Code Search
What is a code?
8641 results found
| C1204 | Tc 99m tilmanocept | Description: Technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries |
| C1879 | Tissue marker, implantable | Description: Tissue marker (implantable) |
| C9130 | Injection, ivig bivigam | Description: Injection, immune globulin (bivigam), 500 mg |
| C9131 | In ado-trastuzumab emtansine | Description: Injection, ado-trastuzumab emtansine, 1 mg |
| C9292 | Injection, pertuzumab | Description: Injection, pertuzumab, 10 mg |
| C9294 | Inj, taliglucerase alfa | Description: Injection, taliglucerase alfa, 10 units |
| C9295 | Injection, carfilzomib | Description: Injection, carfilzomib, 1 mg |
| C9296 | Injection, ziv-aflibercept | Description: Injection, ziv-aflibercept, 1 mg |
| C9297 | Omacetaxine mepesuccinate | Description: Injection, omacetaxine mepesuccinate, 0.01 mg |
| C9298 | Injection, ocriplasmin | Description: Injection, ocriplasmin, 0.125 mg |
| C9736 | Lap ablate uteri fibroid rf | Description: Laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed |
| G0275 | Renal angio, cardiac cath | Description: Renal angiography, non-selective, one or both kidneys, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of any catheter in the abdominal aorta at or near the origins (ostia) of the renal arteries, injection of dye, flush aortogram, production of permanent images, and radiologic supervision and interpretation (list separately in addition to primary procedure) |
| G8459 | Doc pt rec antivir treat | Description: Clinician documented that patient is receiving antiviral treatment for hepatitis c |
| G8462 | Pt inelig couns no antvir tx | Description: Clinician documented that patient is not an eligible candidate for counseling regarding contraception prior to antiviral treatment; patient not receiving antiviral treatment for hepatitis c |
| G8463 | Pt rec antiviral treat doc | Description: Patient receiving antiviral treatment for hepatitis c documented |
| G8556 | Ref to doc otolog eval | Description: Referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation |
| G8557 | Pt inelig ref otolog eval | Description: Patient is not eligible for the referral for otologic evaluation measure |
| G8558 | No ref to doc otolog eval | Description: Not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given |
| G8588 | Sys bp <140 | Description: Most recent systolic blood pressure < 140 mmhg |
| G8589 | Sys bp >= 140 | Description: Most recent systolic blood pressure >= 140 mmhg |
| G8590 | Dia bp < 90 | Description: Most recent diastolic blood pressure < 90 mmhg |
| G8591 | Dia bp >= 90 | Description: Most recent diastolic blood pressure >= 90 mmhg |
| G8592 | No bp measure | Description: No documentation of blood pressure measurement, reason not given |
| G8596 | No ldl perf | Description: Ldl-c was not performed |
| G8603 | Spok lang comp score | Description: Score on the spoken language comprehension functional communication measure at discharge was higher than at admission |
| G8604 | No high score spok lang | Description: Score on the spoken language comprehension functional communication measure at discharge was not higher than at admission, reason not given |
| G8605 | No spok lang comp score | Description: Patient treated for spoken language comprehension but not scored on the spoken language comprehension functional communication measure either at admission or at discharge |
| G8606 | Attention score | Description: Score on the attention functional communication measure at discharge was higher than at admission |
| G8607 | No high score attention | Description: Score on the attention functional communication measure at discharge was not higher than at admission, reason not given |
| G8608 | No attention score | Description: Patient treated for attention but not scored on the attention functional communication measure either at admission or at discharge |
| G8609 | Memory score | Description: Score on the memory functional communication measure at discharge was higher than at admission |
| G8610 | No high score memory | Description: Score on the memory functional communication measure at discharge was not higher than at admission, reason not given |
| G8611 | No memory score | Description: Patient treated for memory but not scored on the memory functional communication measure either at admission or at discharge |
| G8612 | Moto speech score | Description: Score on the motor speech functional communication measure at discharge was higher than at admission |
| G8613 | No high score moto speech | Description: Score on the motor speech functional communication measure at discharge was not higher than at admission, reason not given |
| G8614 | No moto speech score | Description: Patient treated for motor speech but not scored on the motor speech comprehension functional communication measure either at admission or at discharge |
| G8615 | Reading score | Description: Score on the reading functional communication measure at discharge was higher than at admission |
| G8616 | No high score reading | Description: Score on the reading functional communication measure at discharge was not higher than at admission, reason not given |
| G8617 | No reading score | Description: Patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge |
| G8618 | Spok lang exp score | Description: Score on the spoken language expression functional communication measure at discharge was higher than at admission |
| G8619 | No high score spok lang exp | Description: Score on the spoken language expression functional communication measure at discharge was not higher than at admission, reason not given |
| G8620 | No spok lang exp score | Description: Patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge |
| G8621 | Writing score | Description: Score on the writing functional communication measure at discharge was higher than at admission |
| G8622 | No high score writing | Description: Score on the writing functional communication measure at discharge was not higher than at admission, reason not given |
| G8623 | No writing score | Description: Patient treated for writing but not scored on the writing functional communication measure either at admission or at discharge |
| G8624 | Swallowing score | Description: Score on the swallowing functional communication measure at discharge was higher than at admission |
| G8625 | No high score swallowing | Description: Score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given |
| G8626 | No swallowing score | Description: Patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge |
| G8642 | Hrdshp rural w/o internet | Description: The eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act |
| G8643 | Hrdshp w/o suff pharm w/erx | Description: The eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act |
| G8644 | Ep no prescribe priv | Description: Eligible professional does not have prescribing privileges |
| G8741 | Not tx spoken lang | Description: Patient not treated for spoken language comprehension disorder |
| G8742 | Not tx attention | Description: Patient not treated for attention disorder |
| G8743 | Not tx memory | Description: Patient not treated for memory disorder |
| G8744 | Not tx motor speech | Description: Patient not treated for motor speech disorder |
| G8745 | Not tx reading | Description: Patient not treated for reading disorder |
| G8746 | Not tx spoken lang express | Description: Patient not treated for spoken language expression disorder |
| G8747 | Not tx writing | Description: Patient not treated for writing disorder |
| G8748 | Not tx swallowing | Description: Patient not treated for swallowing disorder |
| G8790 | Systolic <130mmhg | Description: Most recent office visit systolic blood pressure <130 mm hg |
| G8791 | Systolic 130-139mmhg | Description: Most recent office visit systolic blood pressure, 130 to 139 mm hg |
| G8792 | Systolic >=140mmhg | Description: Most recent office visit systolic blood pressure >=140 mm hg |
| G8793 | Diastolic <80mmhg | Description: Most recent office visit diastolic blood pressure, <80 mm hg |
| G8794 | Diastolic 80-89mmhg | Description: Most recent office visit diastolic blood pressure, 80 - 89 mm hg |
| G8795 | Diastolic >=90mmhg | Description: Most recent office visit diastolic blood pressure >=90 mm hg |
| G8796 | Bp not doc | Description: Blood pressure measurement not documented, reason not given |
| G8799 | Anticoag ordered | Description: Anticoagulation ordered |
| G8800 | Doc reas anticoag not order | Description: Anticoagulation not ordered for reasons documented by clinician |
| G8801 | Anticoag not ordered | Description: Anticoagulation was not ordered, reason not given |
| G8812 | Pt not elig cta, duplex, mra | Description: Patient is not eligible for follow-up cta, duplex, or mra (e.g., patient death, failure to return for scheduled follow-up exam, planned follow-up study which will meet numerator criteria has not yet occurred at the time of reporting) |
| G8813 | Cta, duplex, mra performed | Description: Follow-up cta, duplex, or mra of the abdomen and pelvis performed |
| G8814 | No cta, duplex, mra | Description: Follow-up cta, duplex, or mra of the abdomen and pelvis not performed |
| G8827 | Aneurysm <= 5.5cm for women | Description: Aneurysm minor diameter <= 5.5 cm for women |
| G8835 | Asymptom no trans | Description: Asymptomatic patient with no history of any transient ischemic attack or stroke in any carotid or vertebrobasilar territory |
| G8919 | Mst rcnt sys bp <140mmg | Description: Most recent systolic blood pressure < 140 mmhg |
| G8920 | Mst rcnt sys bp >=140mmhg | Description: Most recent systolic blood pressure >= 140 mmhg |
| G8921 | Mst rcnt dia bp <90mmhg | Description: Most recent diastolic blood pressure < 90 mmhg |
| G8922 | Mst rcnt dia bp >=90mmhg | Description: Most recent diastolic blood pressure >= 90 mmhg |
| G8945 | Aneurysm <=6 cm for men | Description: Aneurysm minor diameter <= 6 cm for men |
| G8954 | Pt data rpt qual clin db reg | Description: Complete and appropriate patient data were reported to a qualified clinical database registry |
| J0152 | Adenosine injection | Description: Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) |
| J0718 | Certolizumab pegol inj | Description: Injection, certolizumab pegol, 1 mg |
| J1441 | Filgrastim 480 mcg injection | Description: Injection, filgrastim (g-csf), 480 mcg |
| J3487 | Zoledronic acid | Description: Injection, zoledronic acid (zometa), 1 mg |
| J3488 | Reclast injection | Description: Injection, zoledronic acid (reclast), 1 mg |
| J9002 | Doxil injection | Description: Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg |
| L0430 | Dewall posture protector | Description: Spinal orthosis, anterior-posterior-lateral control, with interface material, custom fitted (dewall posture protector only) |
| Q0090 | Skyla 13.5mg | Description: Levonorgestrel-releasing intrauterine contraceptive system, (skyla), 13.5 mg |
| Q0165 | Prochlorperazine maleate10mg | Description: Prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0168 | Dronabinol 5mg oral | Description: Dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0170 | Promethazine hcl 25 mg oral | Description: Promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0171 | Chlorpromazine hcl 10mg oral | Description: Chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0172 | Chlorpromazine hcl 25mg oral | Description: Chlorpromazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0176 | Perphenazine 8mg oral | Description: Perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0178 | Hydroxyzine pamoate 50mg | Description: Hydroxyzine pamoate, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0505 | Miscl supply/accessory vad | Description: Miscellaneous supply or accessory for use with ventricular assist device |
| Q2027 | Sculptra injection | Description: Injection, sculptra, 0.1 ml |
| Q2033 | Influenza vaccine, (flublok) | Description: Influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) |
| Q2051 | Zoldedronic acid 1mg | Description: Injection, zoledronic acid, not otherwise specified, 1mg |
| Q3025 | Im inj interferon beta 1-a | Description: Injection, interferon beta-1a, 11 mcg for intramuscular use |